As of Feb 03, 2025, Prestige Consumer Healthcare Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $73.1. This suggests it may be overvalued by (2.9%) compared to its current price of around $75.3, using a WACC of 6.2% and growth rates of 3.0%.
As of Feb 03, 2025, Prestige Consumer Healthcare Inc.'s Weighted Average Cost of Capital (WACC) is approximately 6.2%.
As of Feb 03, 2025, Prestige Consumer Healthcare Inc.'s Enterprise Value (EV) is approximately $4,731.0M. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.